In turn, antibody-negative ALE patients showed a shift from CD8+ Tc to CD4+ Tc in the PB, which was not visible in CNS-DLBCL patients (Fig. 1B, E, G, J). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.